Eisler Capital (US)’s Pfizer PFE Stock Holding History

Eisler Capital (US)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.5M	Sell	51,900 -134,500	-72%	-$3.92M	0.03%	350
2024 Q2	$5.22M	Buy	186,400 +162,800	+690%	+$4.48M	0.09%	190
2024 Q1	$655K	Sell	23,600 -117,300	-83%	-$3.25M	0.02%	459
2023 Q4	$4.06M	Buy	140,900 +74,600	+113%	+$2.26M	0.13%	153
2023 Q3	$2.2M	Sell	66,300 -15,000	-18%	-$530K	0.06%	223
2023 Q2	$2.98M	Buy	+81,300	New	+$3.16M	0.1%	163

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Eisler Capital (US)'s PFE Position: Q3 2024 in Review

Eisler Capital (US) opened a new position in Pfizer (PFE) in Q3 2024: 23,267 shares worth $673K. The stake represents 0.01% of the portfolio and ranks #410 among its holdings. This is a return to the name: Eisler Capital (US) previously reported a position in PFE as recently as Q3 2023.

Eisler Capital (US) first reported a position in PFE in Q1 2023 and has held it in 4 quarters since. The position peaked at $2.27M in Q3 2023. 2,911 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Eisler Capital (US) held 23,267 shares of Pfizer worth $673K as of Q3 2024.
Pfizer was a new Eisler Capital (US) position in Q3 2024.
Pfizer made up 0.01% of Eisler Capital (US)'s portfolio in Q3 2024, its #410 holding.
Eisler Capital (US) first reported a position in Pfizer in Q1 2023 and has held it in 4 quarters since.
Eisler Capital (US)'s Pfizer position peaked at $2.27M in Q3 2023.
2,911 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.